LUS-22231-67210
1 vaccination
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 443 / OH
- Registered
- 2021-08-14
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-08-14
Registered in v-safe
-
2021-08-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Muscle or body achesAdult check-in
- 2021-08-17
- 2021-08-24
- 2021-09-02
- 2021-09-09
- 2021-09-15
- 2021-09-22
- 2022-02-08
-
2022-08-12
Survey response — 12 months, dose 1MedDRA: Chills, Headache, Nausea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe headache nausea and chillsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Janssen/Johnson & Johnson | No |
Free text
Release 12 — 12 months, dose 1
Symptoms: Severe headache nausea and chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release